Procurement Footprint
Glaxosmithkline — public-sector procurement footprint
From open OCDS records, AqlData resolved 482 name-spelling variants of Glaxosmithkline into one identity (482 legal entities) and mapped its public-sector footprint: 40 countries, ~$18.0B in awarded value (FX-approx, indicative), across 12,600+ tracked contracts (2003-02-03 – 2026-06-10).
40
countries
$18.0B
awarded value *
12,600+
tracked contracts
2,132
public buyers
* ok-quality, FX-converted contracts only (no_value / no_fx / outlier records excluded). Indicative at current spot FX — not historical rates.
Geographic reach
| Country | Contracts | ~Value ($M) |
|---|---|---|
| EU | 522 | 4,488.7 |
| IT | 1,748 | 3,109.0 |
| ES | 1,059 | 1,946.8 |
| GB | 177 | 1,738.8 |
| BE | 20 | 1,050.9 |
| DE | 123 | 986.7 |
| + 34 more countries | in full report | — |
Top public buyers
| Buyer | Country | Contracts |
|---|---|---|
| Dirección General de la Salud | UY | 452 |
| Unidade Local de Saúde do Norte Alentejano, E. P. E. | PT | 242 |
| Centro Hospitalar Vila Nova de Gaia - Espinho, E. P. E | PT | 194 |
| + 2,129 more buyers — every agency, contract-level | — | in full report |
Activity over time
2015794
2016627
2017670
2018865
20191,002
2020721
2021651
20221,548
20231,158
2024985
2025546
2026125
The full due-diligence report
All 40 countries, every one of 2,132 public buyers at the contract level, single-customer revenue concentration, the top-5 buyer split and the buyer-level competitor map — the complete Glaxosmithkline due-diligence brief, delivered within 24 hours.
Order this report — $499Request a worked sample